
Ardian acquires Italmatch from Mandarin
Mandarin Capital Partners has sold its 67.6% stake in Italmatch Chemicals to Ardian, marking the company's fifth private equity-backed buyout.
Ardian has also acquired the stake of the Malacalza family. Italmatch's senior management, including its CEO Sergio Iorio, has retained its 12% shareholding.
The exit will achieve a 40% IRR for Mandarin's first fund, the €350m Mandarin Capital Partners vehicle. The deal marks the fifth exit for the fund.
Ardian's plans for the company include international expansion with a focus on the US and Asia. The business has been following an acquisitive growth strategy in recent years, with its most recent bolt-ons those of Dequest's phosphonates business and Thermphos International's phosphorus chlorides business last year.
Mandarin picked up Italmatch in November 2010, acquiring a 70% stake in a deal valued at around €100m. The Sino-European firm acquired the company via its €350m Mandarin Capital Partners vehicle. The Malacalza family purchased a 20% stake at the same time, with management acquiring 10%. The parties bought the business from Investindustrial, which reaped an IRR of 35% and a money multiple of 3.5x from the sale, according to unquote" data.
Investindustrial had acquired Italmatch in July 2004, purchasing a 90% stake for around €15m and marking the second time the company has been under its ownership. Investindustrial originally acquired Italmatch in September 1997 alongside Iniziativa Piemonte for around €11.2m in total, before selling the business to Argos Soditic in January 2001 for approximately €25.8m, €18m of which was provided as debt by GE Capital Interbanca.
Company
Founded in 1997 through the Investindustrial-backed management buyout from Saffa Group – which was established in 1929 – Italmatch is headquartered in Genoa with five production sites based in Spoleto and Arese in Italy, Frankfurt in Germany, Zuera in Spain and Newport in the UK. The company also has two production facilities in China and Japan.
Italmatch is a manufacturer of speciality chemicals, namely phosphorus derivatives. Products include phosphorus-based additives for engine lubricant oil and plastics.
Its recent acquisitive strategy is intended to build its market share and product base within the areas of oil and gas, water treatment and lubricants for industrial applications.
The company is expecting to reach turnover of €250m this year, which it says is double its turnover for 2013, as well as an EBITDA of €30m. At the time of Mandarin's acquisition of the company, it generated €90m is revenues and an EBITDA of €18m.
People
Sergio Iorio is the CEO of Italmatch. Philippe Poletti is head of Ardian's mid-cap team.
Advisers
Equity – Fineurop Soditic (M&A); Advancy (Commercial due diligence); KPMG (Financial due diligence); CBA (Tax); Tauw (Environmental due diligence); Giovannelli & Associati (Legal).
Management – Studio Jenny & Partner, Gianmarco Mileni (Legal); Studio STLex Studio Legale e Tributario, Giovanni Ciurlo (Tax).
Vendors – Studio LMCR, Robert Rio (Legal); MGMP & Associati, Paolo Terrile (Legal); Deloitte (Tax).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater